Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Jaypirca - labeled renal guidance
Product / population
Pirtobrutinib (Jaypirca), adult oral tablets
Renal method
eGFR, mL/min as printed in the dosage subsection; indexing not specified there
Source revision
DailyMed SPL version 16, effective 2026-10-02; posted Oct 19, 2026
Renal method: eGFR, mL/min as printed in the dosage subsection; indexing not specified there Source date: DailyMed SPL version 16, effective 2026-10-02; posted Oct 19, 2026 Retrieved: 2026-11-07
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
At eGFR 15-29 mL/min: reduce 200 mg daily to 100 mg daily. For other current doses, lower by 50 mg daily; discontinue if already taking 50 mg daily. At 30-89 there is no renal change. Use the current dose and the eGFR units as printed in the label. The selected bands do not establish a dialysis regimen.
RDM73-jaypirca-official-1 · Source locator: Renal guidance: 2.3 and 8.6
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
